Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)

Circulation. Cardiovascular Quality and Outcomes
Zugui ZhangJohn A Spertus

Abstract

Percutaneous coronary intervention (PCI) is a therapy to reduce angina and improve quality of life in patients with stable ischemic heart disease. However, it is unclear whether the quality of life after PCI is more dependent on the PCI or other patient-related factors. To address this question, we created models to predict angina and quality of life 1 year after PCI and medical therapy. Using data from the 2287 stable ischemic heart disease patients randomized in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) to PCI plus optimal medical therapy (OMT) versus OMT alone, we built prediction models for 1-year Seattle Angina Questionnaire angina frequency, physical limitation, and quality of life scores, both as continuous outcomes and categorized by clinically desirable states, using multivariable techniques. Although most patients improved regardless of treatment, marked variability was observed in Seattle Angina Questionnaire scores 1 year after randomization. Adding PCI conferred a greater mean improvement (about 2 points) in Seattle Angina Questionnaire scores that were not affected by patient characteristics (P values for all interactions >0.05). The proportion of patients fre...Continue Reading

References

May 1, 1985·Journal of the American College of Cardiology·R M CaliffG S Wagner
Dec 15, 1994·The American Journal of Cardiology·J A SpertusS D Fihn
Apr 4, 2001·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·P C AustinJ A Kopec
Jul 10, 2002·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Peter C Austin
Dec 15, 2004·Circulation·John A SpertusRandall C Thompson
Apr 15, 2006·BMC Medical Research Methodology·Rodney A HaywardTimothy P Hofer
Jun 20, 2006·American Heart Journal·William E BodenUNKNOWN COURAGE trial coprincipal investigators and study coordinators
Mar 28, 2007·The New England Journal of Medicine·William E BodenUNKNOWN COURAGE Trial Research Group
Aug 19, 2007·Archives of Internal Medicine·Grace A LinRita F Redberg
Feb 6, 2008·The International Journal of Cardiovascular Imaging·O OzkanU Ozcan
Aug 16, 2008·The New England Journal of Medicine·William S WeintraubG B J Mancini
Dec 18, 2008·Source Code for Biology and Medicine·Zoran BursacDavid W Hosmer
Sep 1, 2008·Circulation. Cardiovascular Quality and Outcomes·Suzanne V ArnoldJohn A Spertus
Mar 25, 2010·JAMA : the Journal of the American Medical Association·Harlan M Krumholz
May 1, 2010·Journal of the American College of Cardiology·Eric D PetersonUNKNOWN NCDR Registry Participants
Jul 11, 2013·Circulation. Cardiovascular Quality and Outcomes·John A SpertusUNKNOWN Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Investigators and Coordinators
Sep 4, 2014·Circulation. Cardiovascular Quality and Outcomes·Paul S ChanJohn A Spertus
Sep 25, 2014·Circulation. Cardiovascular Quality and Outcomes·Suzanne V ArnoldJohn A Spertus
Apr 22, 2016·JAMA : the Journal of the American Medical Association·Erica S SpatzBenjamin W Moulton
Apr 30, 2016·Annals of Translational Medicine·Zhongheng Zhang
Jul 1, 2015·European Heart Journal. Quality of Care & Clinical Outcomes·Suzanne V ArnoldJohn A Spertus

❮ Previous
Next ❯

Citations

Jun 6, 2020·Mayo Clinic Proceedings·Mandeep SinghMohammed A Al-Hijji
Sep 26, 2020·Journal of the American College of Cardiology·Issam D MoussaChuck Simonton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Circulation. Cardiovascular Quality and Outcomes
William S WeintraubDepartment of Veterans Affairs Cooperative Studies Program No. 424 (COURAGE Trial) Investigators and Study Coordinators
Circulation. Cardiovascular Quality and Outcomes
John A SpertusClinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Investigators and Coordinators
Circulation. Cardiovascular Quality and Outcomes
Bina AhmedNorthern New England Cardiovascular Disease Study
© 2022 Meta ULC. All rights reserved